Novel targets for skin health

Our aim

  • We are looking for novel targets and concepts in the treatment of dermatological diseases
    • Targets can be proteins or nucleic acids whose function can be modulated by a small molecule or biological therapy; which have a scientific rationale in a disease of interest, but which have not been necessarily validated in that indication
    • Concepts can be mechanisms, pathways, or cell players not previously linked to a disease of interest

Our partners

  • Universities
  • Research Centers
  • Start-ups and Biotechs
  • Pharmaceutical companies

world-wide with an interest in pharmaceutical R&D

Your benefits

  • Research grants from €25000 to €100000
    • Funding to be granted at Almirall’s discretion
    • Final amount will depend on the specific proposal and it may be provided in one or several installment
  • Intellectual property rights with the applicant
    • You will retain ownership of any intellectual property you may bring or develop
  • Additional scientific support will be provided on an ad-hoc basis
    • Mentorship by Almirall experts to advance the initial proposal to meet project criteria
    • Technology platforms to assist in your target validation
    • Pharmacological tools
    • Advise for intellectual property matters
  • A specific contact person to help you with any questions available at any time
  • Further collaboration envisioned beyond the initial project

Collaboration process

  • Proposal submission
    • The first step is for you to create an account on the AlmirallShare Innovation platform, which is a secure site to store and manage your proposals
    • The call will be opened from October 8th, 2018 to February 28th, 2019
    • Please include an outline of your idea (max. 300 words) and a detailed description of your proposal attaching documents/publications that support it
    • All the initial information provided under the proposal should be non-confidential
  • Proposal evaluation and selection
    • A team of Almirall scientific experts will evaluate your proposal
    • The evaluation process will be completed 8-10 weeks after the submission deadline
    • After the evaluation period, you will receive Almirall’s decision on your proposal
  • Start of collaboration
    • If your proposal has been selected, the Shared Innovation team will help you with the collaboration agreement
    • An Almirall scientist will be assigned to collaborate with you on project definition as well as project follow-up

For Universities, Research Centers, Start-ups, Biotechs and Pharma companies

€25.000 to €100.000
Open from 10/10/18 to 02/03/19